FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies
CNBC • U.S. • 30 minutes ago
If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA's drug shortage list.
Related News
The pastor of the nation’s largest Methodist church is running for the US Senate in Kansas
The pastor of the largest United Methodist Church in the U.S. has launched a campaign for the Democratic nomination for…
Trump Administration Imposes Caps on Graduate School Loans
The changes stem from student loan provisions in a sprawling tax and domestic policy bill signed into law last year.
Trump to get briefed on potential Iran strikes before war hits key 60-day deadline: Reports
Iran has rejected further negotiations unless the U.S. blockade is lifted, but President Trump has said he won't do so …
CNBC
• 25 minutes ago
Harvey Weinstein's lawyers question his accuser at his rape retrial
Harvey Weinstein’s lawyers are getting their chance to query his accuser at his rape retrial
After Supreme Court Decision, Louisiana Weighs Redrawing House Maps
It was not immediately clear whether Gov. Jeff Landry, a Republican, would postpone the May 16 primary election for Hou…
Meta tanks 10%, Alphabet climbs 5% as each company raises capex spend
Both Alphabet and Meta said they expect their capex to continue growing this year, but investors sent Alphabet's shares…
CNBC
• 1 hour ago